VerifiedBiotechnology Research· Founded 2016

Mabpro Therapeutics

Personalized cancer immunotherapy for aggressive hypoxic tumors with blockbuster potential. Our Target Mechanism For Treating Hypoxic Tumors: Carbonic Anhydrase IX (CA IX). Our Mission- to fill the gap in treatment of oncology diseases with poor prognosis- to increase survival rate and bring hope to patients who have undergone different types of therapies without success- to deliver novel therapeutics that match the principle of personalized medicine which will help patients to improve the quality of their lives. Crunchbase

7-day free trial · no credit card

Bratislava, Slovakia11(11 to 50)2016mabpro.sk LinkedIn

Verified contacts

available on Kipplo

LinkedIn employees

11 to 50 range

Open roles

—

no listings

Distinct roles

indexed titles

Tech stack

tools in use

Monthly traffic

organic / mo

Free for 7 days · 50 credits · no card · only pay for verified records.

Decision-makers and verified team members

8 contacts with verified email or phone · masked until revealed.

Showing 5 of 8 verified contacts

Top roles at Mabpro Therapeutics

8 distinct titles indexed · top 8 shown.

1chairman of the board
1chairman of the supervisory board
1chief executive officer
1chief medical officer
1head of legal
1medical director
1project manager
1vice president clinical research

Free for 7 days · 50 credits · no card · only pay for verified records.

Sign up to reveal 8 verified contacts at Mabpro Therapeutics

7-day trial · no credit card · cancel anytime · only pay for verified records.

Trusted by sales, marketing, and GTM engineering teams.